EXECUTIVE CHANGES: IDE CFO departs; Griffin hires former Dignity chair Read More
BROKER RATINGS: Berenberg raises Rightmove to Hold from Sell Read More
IN BRIEF: GlaxoSmithKline seeks approval in US for use of Priorix Read More
BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda Read More
TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook Read More
BROKER RATINGS: Citi resumes Melrose at Buy; Peel cuts Pets At Home Read More
TOP NEWS: GSK retains guidance despite weaker interim results Read More
LONDON MARKET MIDDAY: Travel and banking stocks lead gains before Fed Read More
GlaxoSmithKline gets US Shingrix approval for immunocompromised adults Read More
GSK to distribute record number of influenza vaccines in US Read More
GSK Consumer Healthcare CEO appointed CEO Designate of demerged firm Read More
UK earnings, trading statements calendar - next 7 days Read More
BROKER RATINGS: RBC upgrades Fresnillo; JPMorgan raises Travis Perkins Read More
UPDATE: Glaxo "particularly pleased" with daprodustat Phase 3 results Read More
IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors Read More
TOP NEWS: Glaxo eyes developer to turn UK asset into life sciences hub Read More
BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties Read More
BROKER RATINGS: Jefferies cuts British Land and Landsec to Hold Read More
Moody's raises GSK outlook to stable as tips debt cut amid spin-off Read More
UPDATE: Glaxo joins Alector on brain treatment trials; backs leader Read More
